News — alternative mental health

Anxiety and depression have become defining mental health challenges of the modern age. Affecting over 300 million people globally, these conditions are not only deeply personal but also represent a significant burden on public health systems. While therapy and pharmacological interventions like SSRIs and benzodiazepines remain mainstream treatments, many patients still report side effects or limited relief, prompting a surge of interest in alternative, cutting-edge approaches.

Enter microdosing psychedelics—a novel and controversial strategy that’s making waves in both the scientific community and popular culture. Unlike traditional psychedelic use, which involves full doses to induce hallucinations, microdosing refers to consuming sub-perceptual amounts of substances like LSD or psilocybin. The goal isn’t to "trip" but to subtly enhance mood, creativity, focus, and emotional resilience. As research expands and public curiosity grows, the question becomes: can this emerging practice offer real hope to those battling anxiety and depression?